NTF6B

Across TCGA pan-cancer cohorts, NTF6B RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated NTF6B data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher NTF6B RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NTF6B expression acts as an unfavorable survival marker.

UCEC, MESO, and KIRC are the cancer types where NTF6B RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.443	0.689	<.001	108	view →
MESO	OS	Tertile	All	0.230	0.553	.006	54	view →
KIRC	DFS	Tertile	IV	0.301	0.520	.040	36	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
LIHC	DFS	Tertile	All	0.126	0.555	.011	18	view →
SKCM	OS	Tertile	All	0.689	0.874	.016	15	view →
KICH	OS	Tertile	All	0.648	0.972	.012	9	view →
BLCA	DFS	Tertile	IV	0.211	0.474	.042	9	view →
CHOL	OS	Tertile	All	0.154	0.793	.004	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

NTF6B–UCEC (OS)

Open the UCEC breakdown →